Patrick Amstutz
Founder chez MOLECULAR PARTNERS AG
Fortune : 3 M $ au 31/03/2024
Profil
Patrick Amstutz is the founder of Molecular Partners AG, a company founded in 2004, where he holds the title of Chief Executive Officer & Director.
He is currently the Chief Executive Officer & Director at Molecular Partners, Inc. and the President at Swiss Biotech Association since 2017.
Dr. Amstutz has a doctorate degree from the University of Zurich and a graduate degree from the Swiss Federal Institute of Technology.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
MOLECULAR PARTNERS AG
2,02% | 31/12/2023 | 735 095 ( 2,02% ) | 3 M $ | 31/03/2024 |
Postes actifs de Patrick Amstutz
Sociétés | Poste | Début |
---|---|---|
MOLECULAR PARTNERS AG | Founder | 23/11/2004 |
Swiss Biotech Association
Swiss Biotech Association Miscellaneous Commercial ServicesCommercial Services Swiss Biotech Association operates as an industry association. The private company is based in Zurich, Switzerland. Michael Altorfer has been the CEO of the Swiss company since 2018. | President | 03/05/2022 |
Molecular Partners, Inc.
Molecular Partners, Inc. Pharmaceuticals: MajorHealth Technology Part of Molecular Partners AG, Molecular Partners, Inc. operates as a clinical-stage biopharmaceutical company. The private company is based in Cambridge, MA. The CEO of the company is Patrick Amstutz. | Chief Executive Officer | - |
Formation de Patrick Amstutz
University of Zurich | Doctorate Degree |
Swiss Federal Institute of Technology | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
MOLECULAR PARTNERS AG | Health Technology |
Entreprise privées | 2 |
---|---|
Swiss Biotech Association
Swiss Biotech Association Miscellaneous Commercial ServicesCommercial Services Swiss Biotech Association operates as an industry association. The private company is based in Zurich, Switzerland. Michael Altorfer has been the CEO of the Swiss company since 2018. | Commercial Services |
Molecular Partners, Inc.
Molecular Partners, Inc. Pharmaceuticals: MajorHealth Technology Part of Molecular Partners AG, Molecular Partners, Inc. operates as a clinical-stage biopharmaceutical company. The private company is based in Cambridge, MA. The CEO of the company is Patrick Amstutz. | Health Technology |